← Back to Search

Arm B for COVID-19 (ENDURE Trial)

Phase 2
Waitlist Available
Research Sponsored by AstraZeneca
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights

ENDURE Trial Summary

This trial is testing a new drug to see if it is safe and effective in preventing COVID-19.

Eligible Conditions
  • COVID-19

ENDURE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adverse Events
Adverse Events of Special Interest
Incidence of ADA in serum
+1 more
Secondary outcome measures
Changes from baseline in GMTs and GMFRs values in SARS-CoV-2 nAbs
Serum AZD7442 concentrations

ENDURE Trial Design

2Treatment groups
Experimental Treatment
Group I: Arm BExperimental Treatment1 Intervention
1200mg AZD7442 following 600 mg AZD7442 every 6 months (3 doses totally)
Group II: Arm AExperimental Treatment1 Intervention
600 mg AZD7442 following 300 mg AZD7442 every 3 months (5 doses totally)

Find a Location

Who is running the clinical trial?

AstraZenecaLead Sponsor
4,259 Previous Clinical Trials
288,593,651 Total Patients Enrolled
52 Trials studying COVID-19
256,197,272 Patients Enrolled for COVID-19

Media Library

Arm B Clinical Trial Eligibility Overview. Trial Name: NCT05375760 — Phase 2
COVID-19 Research Study Groups: Arm B, Arm A
COVID-19 Clinical Trial 2023: Arm B Highlights & Side Effects. Trial Name: NCT05375760 — Phase 2
Arm B 2023 Treatment Timeline for Medical Study. Trial Name: NCT05375760 — Phase 2
COVID-19 Patient Testimony for trial: Trial Name: NCT05375760 — Phase 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Can people with the qualifying condition join this trial at present?

"The latest information available on clinicaltrials.gov indicates that this study is not actively recruiting patients at this time. The trial was first posted on June 9th, 2022 and last updated November 7th, 2022. There are 1146 other trials which are currently looking for participants."

Answered by AI

Does this experiment exclude senior citizens?

"The age bracket for participants in this clinical trial are those that are 12 years old or above, and have not yet reached their 100th birthday."

Answered by AI

Could you give me the screening criteria for this research project?

"The eligibility requirements for this study include a positive diagnosis of covid-19 and an age between 12 to 99 years old. So far, 251 have been accepted into the trial."

Answered by AI

How does this treatment's safety profile compare to other available options?

"The safety of this proposed treatment falls in the middle of our 1 to 3 scale at a 2. This is due to the fact that, while there is Phase 2 clinical trial data supporting its safety, there are no trials which have evaluated efficacy."

Answered by AI

In how many different healthcare facilities is this research project being conducted today?

"This trial is currently running at 17 sites. The locations are listed on the website and include Lake City, Miami Lakes and Modesto along with 14 other locations. If you enroll, it would be helpful to select the site that is closest to your location in order to minimize travel requirements."

Answered by AI

Who else is applying?

What state do they live in?
California
What site did they apply to?
Research Site
What portion of applicants met pre-screening criteria?
Did not meet criteria
How many prior treatments have patients received?
0

Why did patients apply to this trial?

I want covid protection against severe symptoms.
PatientReceived 1 prior treatment
~89 spots leftby Apr 2025